Legorreta Pablo G.

Average Profitability
<0.0001%
Insider Buys Quantity
8
Insider Buys Sum
$74.33M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Legorreta Pablo G.

According to the SEC Form 4 filings, Legorreta Pablo G., being in a position of

  1. at ProKidney Corp.,
    оver the last 12 months, has bought 22617909 shares for $54.74M, and sold 0 shares,
    over all time since 2024-06-13, has bought 22617909 shares for $54.74M, and sold 0 shares.

The largest purchase of all time was on 2024-06-13 and amounted to 22617909 shares of ProKidney Corp. for $54.74M.

Biography of Legorreta Pablo G.

No biography is available at this moment.

2024-06-13PurchaseProKidney Corp.
PROK
22.62M
9.3818%
$2.42$54.74M-28.62%
2023-06-28PurchaseRoyalty Pharma plc
RPRX
CEO, Chairman of the Board
130,000
0.0324%
$29.51$3.84M-2.6%
2023-06-13PurchaseRoyalty Pharma plc
RPRX
CEO, Chairman of the Board
45,000
0.0125%
$32.78$1.47M-10.4%
2023-06-12PurchaseRoyalty Pharma plc
RPRX
CEO, Chairman of the Board
45,000
0.0125%
$33.00$1.48M-11.51%
2023-05-24PurchaseRoyalty Pharma plc
RPRX
CEO, Chairman of the Board
150,000
0.0408%
$32.25$4.84M-9.04%
2023-05-17PurchaseRoyalty Pharma plc
RPRX
CEO, Chairman of the Board
69,612
0.0194%
$32.94$2.29M-10.12%
2023-05-16PurchaseRoyalty Pharma plc
RPRX
CEO, Chairman of the Board
160,388
0.0455%
$33.57$5.38M-10.8%
2020-06-18PurchaseRoyalty Pharma plc
RPRX
CEO, Chairman of the Board
10,000
0.0024%
$28.00$280,000-14.2%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.